Zhao et al. evidenced that ECs are a substantial component of the TME for their contribution to boosting metastatic activity via silencing AR expression and transcriptional activity; therefore, their inhibition could impede PCa progression [120]. The gene discussed is AR; the disease is posterior cortical atrophy.